• News (165)
    Financial Times (14 Feb 2019)

    Johnson & Johnson to buy robotics group Auris Health for $3.4bn

    JOHNSON & JOHNSON has announced its $3.4bn acquisition of robotics outfit Auris Health. The purchase is intended to bolster Johnson & Johnson's presence in the digital surgery market. Auris Health has already released its first FDA-approved product which allows surgeons to reach small and typically hard-to-access lung nodules, meaning cancer can be spotted and treated earlier. Johnson & Johnson is one of many pharmaceutical businesses investing in medical technology to give them a competitive edge before patent protection on their key drug products runs out.

    Read Full Article

    Exclusive (16 Nov 2018)

    JOHNSON & JOHNSON has appointed Sabine O'Dwyer to the role of assistant brand manager, marketing.